ProMIS Neurosciences Statistics
Total Valuation
PMN has a market cap or net worth of $39.67 million. The enterprise value is $37.14 million.
| Market Cap | 39.67M |
| Enterprise Value | 37.14M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PMN has 18.96 million shares outstanding. The number of shares has increased by 127.69% in one year.
| Shares Outstanding | 18.96M |
| Shares Change (YoY) | +127.69% |
| Shares Change (QoQ) | +58.91% |
| Owned by Insiders (%) | 24.33% |
| Owned by Institutions (%) | 17.89% |
| Float | 10.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 514.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34, with zero debt.
| Current Ratio | 1.34 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -41.74 |
Financial Efficiency
Return on equity (ROE) is -2,311.80% and return on invested capital (ROIC) is -16,820.86%.
| Return on Equity (ROE) | -2,311.80% |
| Return on Assets (ROA) | -130.10% |
| Return on Capital (ROIC) | -16,820.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.70M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.28% in the last 52 weeks. The beta is 0.66, so PMN's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -60.28% |
| 50-Day Moving Average | 1.80 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 59.05 |
| Average Volume (20 Days) | 9,134 |
Short Selling Information
The latest short interest is 15,385, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 15,385 |
| Short Previous Month | 10,684 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.14% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.97M |
| Pretax Income | -11.89M |
| Net Income | -11.89M |
| EBITDA | -11.59M |
| EBIT | -11.61M |
| Earnings Per Share (EPS) | -$0.74 |
Balance Sheet
The company has $2.53 million in cash and no debt, giving a net cash position of $2.53 million or $0.13 per share.
| Cash & Cash Equivalents | 2.53M |
| Total Debt | n/a |
| Net Cash | 2.53M |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | 77,099 |
| Book Value Per Share | 0.00 |
| Working Capital | 902,386 |
Cash Flow
| Operating Cash Flow | -18.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | -18.57M |
| FCF Per Share | -$0.95 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -127.69% |
| Shareholder Yield | -127.69% |
| Earnings Yield | -29.97% |
| FCF Yield | -46.82% |
Analyst Forecast
The average price target for PMN is $8.00, which is 302.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 302.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 28, 2022. It was a reverse split with a ratio of 1:60.
| Last Split Date | Jun 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |